QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS1-Region Domestic Shipping
What is SLU-PP-332?
SLU-PP-332 100mg is the highest available tablet dose — providing maximal ERRα/ERRγ agonist loading per unit for research protocols requiring maximum receptor engagement, comparative PK studies, or sustained-high-concentration tissue exposure experiments. Research use only.
Research Applications
Maximum Dose PK/PD
Cmax, AUC, oral bioavailability at 100mg; tissue distribution modelling
ERR Pathway Saturation
Complete transcriptional program activation, feedback regulation, receptor recycling
Comparative Dose Research
Full 500mcg–100mg dose ladder — Emax, EC50, Hill coefficient determination
Sustained Energy Metabolism
Prolonged mitochondrial biogenesis, β-oxidation, ketogenesis interaction
Preclinical Toxicology
NOAEL estimation, organ-specific biomarkers at maximal dose
Quick Specs
| Form | Tablet — 100mg per tablet, 60-tablet bottle |
| CAS Number | 2411025-13-3 |
| Molecular Formula | C₂₄H₂₃N₃O₃ |
| Molecular Weight | 405.5 g/mol |
| Compound Type | ERRα/ERRγ Nuclear Receptor Agonist |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage |
| Shelf Life | 24 months unopened |

